SynthesisBMC cancer2024

Efficacy and safety of second-line therapies for advanced hepatocellular carcinoma: a network meta-analysis of randomized controlled trials.

Fenping Lu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.